Patents by Inventor Charles Good

Charles Good has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160232238
    Abstract: A method of semantic searching. The method may include receiving a first search query, obtaining a disambiguation term for semantically disambiguating the first search query, and creating, with a processor, a second search query based at least in part on the first search query and the disambiguation term. The method may also include at least one of outputting search results obtained from a search conducted based at least in part on the second search query and sending the second search query to a search service for outputting search results.
    Type: Application
    Filed: April 8, 2016
    Publication date: August 11, 2016
    Applicant: Primal Fusion Inc.
    Inventors: Peter Joseph Sweeney, Robert Charles Good
  • Patent number: 9361365
    Abstract: A method of semantic searching. The method may include receiving a first search query, obtaining a disambiguation term for semantically disambiguating the first search query, and creating, with a processor, a second search query based at least in part on the first search query and the disambiguation term. The method may also include at least one of outputting search results obtained from a search conducted based at least in part on the second search query and sending the second search query to a search service for outputting search results.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: June 7, 2016
    Assignee: Primal Fusion Inc.
    Inventors: Peter J. Sweeney, Robert Charles Good
  • Publication number: 20150224806
    Abstract: The present magnetically bound media with reattachable pages exemplarily comprise a magnetic binding, one or more reattachable pages, and one or more conductive metals attached to the pages and magnetically attracted to the magnetic binding. Thus, a user of the magnetically bound media may disengage one or more of the pages from the magnetic binding and reintegrate those pages into the magnetic binding in any order. This allows for customization of information presentation, sequence, and selection. The small size of the magnetic binding also affords a smaller minimum apparatus size and a quicker means with which to remove, rearrange, and reintegrate pages. Furthermore, the magnetic binding permits pages to be secured in a more professionally presentable manner without punched holes. In an exemplary embodiment, the magnetic binding is a cylindrical or a prismatic, rectangular neodymium or samarium alloy secured within the bound media by a magnet cover or clasp.
    Type: Application
    Filed: February 12, 2014
    Publication date: August 13, 2015
    Inventor: Charles Good-Man
  • Patent number: 8799766
    Abstract: Processing changes to a document is disclosed. An indication that changes, if any, affecting the document or a portion thereof are to be reviewed is received. The document comprises one or more segments each of which is configured to be generated automatically based at least in part on data from a data source associated with the segment. An ability to review a subset of changes affecting the document is provided, where the changes in the subset affect particular segment(s) of the document.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: August 5, 2014
    Assignee: Adobe Systems Incorporated
    Inventor: Charles Good
  • Publication number: 20140013209
    Abstract: Processing changes to a document is disclosed. An indication that changes, if any, affecting the document or a portion thereof are to be reviewed is received. The document comprises one or more segments each of which is configured to be generated automatically based at least in part on data from a data source associated with the segment. An ability to review a subset of changes affecting the document is provided, where the changes in the subset affect particular segment(s) of the document.
    Type: Application
    Filed: October 3, 2005
    Publication date: January 9, 2014
    Inventor: Charles Good
  • Publication number: 20120330019
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: August 29, 2012
    Publication date: December 27, 2012
    Inventors: Xiangdong Alan Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Piyasena Hewawasam, Andrew Charles Good, Yan Chen, Jeffrey Allen Campbell
  • Patent number: 8185820
    Abstract: Embodiments of methods, apparatuses, devices and systems associated with document generation are disclosed. For example, methods, apparatuses, devices, and systems associated with formatting content for display are disclosed. Including method apparatuses, devices, and systems to read a data file and a template file, create one or more sub-assemblies based at least in part on said template file and/or said data file; and execute one or more tags in said template file to populate said one or more sub-assemblies with data from said data file.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: May 22, 2012
    Assignee: Adobe Systems Incorporated
    Inventor: Charles Good
  • Publication number: 20110314006
    Abstract: A method of semantic searching. The method may include receiving a first search query, obtaining a disambiguation term for semantically disambiguating the first search query, and creating, with a processor, a second search query based at least in part on the first search query and the disambiguation term. The method may also include at least one of outputting search results obtained from a search conducted based at least in part on the second search query and sending the second search query to a search service for outputting search results.
    Type: Application
    Filed: June 16, 2011
    Publication date: December 22, 2011
    Applicant: Primal Fusion Inc.
    Inventors: Peter J. Sweeney, Robert Charles Good
  • Patent number: 7741281
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R?, R3, R3?, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 1, 2006
    Date of Patent: June 22, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Stanley D'Andrea, Zhizhen Barbara Zheng, Jeffrey Allen Campbell, Fiona McPhee, Andrew Charles Good, Paul Michael Scola
  • Patent number: 7592336
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: September 22, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ny Sin, Paul Michael Scola, Nicholas A. Meanwell, Xiangdong Alan Wang, Li-Qiang Sun, Jie Chen, Andrew Charles Good
  • Patent number: 7449479
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: November 11, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Xiangdong Alan Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Piyasena Hewawasam, Andrew Charles Good, Yan Chen, Jeffrey Allen Campbell
  • Publication number: 20080152619
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: May 9, 2006
    Publication date: June 26, 2008
    Inventors: Ny Sin, Paul Michael Scola, Nicholas A. Meanwell, Xiangdong Alan Wang, Li-Qiang Sun, Jie Chen, Andrew Charles Good
  • Patent number: 7323447
    Abstract: The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which inhibit the function of the NS3 protease (also referred to herein as “serine protease”) encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS3 protease.
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: January 29, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ny Sin, Andrew Charles Good, Brian Lee Venables, Paul Michael Scola, Nicholas A. Meanwell
  • Patent number: 7309708
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: December 18, 2007
    Assignee: Birstol-Myers Squibb Company
    Inventors: Yong Tu, Paul Michael Scola, Andrew Charles Good, Jeffrey Allen Campbell
  • Patent number: 7173004
    Abstract: Macrocyclic isoquinoline peptides are disclosed having the general formula: A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: February 6, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Fiona McPhee, Jeffrey Allen Campbell, Stanley D'Andrea, Zhizhen Barbara Zheng, Andrew Charles Good, David J. Carini, Barry L. Johnson, Paul Michael Scola, Kenneth M. Boy
  • Patent number: 7041698
    Abstract: The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: May 9, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Amy Ripka, Jeffrey Allen Campbell, Andrew Charles Good, Paul Michael Scola, Ny Sin, Brian Venables
  • Patent number: 6995174
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: February 7, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Xiangdong Alan Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Piyasena Hewawasam, Andrew Charles Good, Yan Chen, Jeffrey Allen Campbell
  • Patent number: 6869964
    Abstract: The present invention relates to tripeptide compounds, compositions containing such compounds and methods for using such compounds for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: March 22, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jeffrey Allen Campbell, Andrew Charles Good
  • Patent number: 6867185
    Abstract: The present invention relates to macrocyclic compounds, methods for making these compounds, pharmaceutical compositions and the therapeutic or prophylactic use of these compounds by administering said compounds to mammals or treat hepatitis C virus (HCV) infection.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: March 15, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jeffrey Allen Campbell, Andrew Charles Good
  • Publication number: 20040106559
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: 1
    Type: Application
    Filed: May 20, 2003
    Publication date: June 3, 2004
    Inventors: Xiangdong Alan Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Piyasena Hewawasam, Andrew Charles Good, Yan Chen, Jeffrey Allen Campbell